Free Trial

Molina Healthcare (NYSE:MOH) Reaches New 1-Year Low - What's Next?

Molina Healthcare logo with Medical background

Key Points

  • Molina Healthcare's stock has reached a new 52-week low at $152.13 amidst trading activity, showing a significant drop from its previous closing price of $158.15.
  • Despite the recent decline, Wall Street analysts have varying ratings, with a consensus rating of "Hold" and an average price target of $244.55.
  • The company's most recent earnings report showed an EPS of $5.48, slightly missing analyst estimates while revenue rose 15.7% year-over-year.
  • Looking to export and analyze Molina Healthcare data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Molina Healthcare, Inc (NYSE:MOH - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $152.13 and last traded at $155.34, with a volume of 1648446 shares trading hands. The stock had previously closed at $158.15.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MOH shares. Truist Financial reissued a "hold" rating and issued a $180.00 price objective (down from $335.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Sanford C. Bernstein initiated coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price target on the stock. Wall Street Zen downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $210.00 price target (down from $312.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $244.55.

Read Our Latest Report on MOH

Molina Healthcare Trading Up 1.2%

The stock has a market capitalization of $8.50 billion, a PE ratio of 7.73 and a beta of 0.52. The firm has a 50 day moving average price of $236.76 and a 200 day moving average price of $286.88. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). The company had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%. The business's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period last year, the company earned $5.86 earnings per share. Equities analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, COO James Woys acquired 10,000 shares of Molina Healthcare stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the purchase, the chief operating officer directly owned 74,331 shares of the company's stock, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ronna Romney sold 700 shares of the company's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director owned 17,131 shares of the company's stock, valued at $2,633,719.94. This trade represents a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Rothschild Investment LLC grew its holdings in Molina Healthcare by 126.3% during the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after purchasing an additional 48 shares during the period. Zions Bancorporation National Association UT bought a new position in Molina Healthcare during the first quarter valued at $29,000. Colonial Trust Co SC grew its holdings in Molina Healthcare by 930.0% during the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after purchasing an additional 93 shares during the period. Deseret Mutual Benefit Administrators grew its holdings in Molina Healthcare by 60.7% during the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after purchasing an additional 34 shares during the period. Finally, Elequin Capital LP boosted its holdings in shares of Molina Healthcare by 170.6% in the first quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after acquiring an additional 58 shares during the period. Institutional investors own 98.50% of the company's stock.

Molina Healthcare Company Profile

(Get Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines